cytarabine has been researched along with pyrogallol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunner, KW | 1 |
| Erker, T; Fritzer-Szekeres, M; Grusch, M; Handler, N; Horvath, Z; Jaeger, W; Krupitza, G; Madlener, S; Murias, M; Saiko, P; Szekeres, T | 1 |
| Erker, T; Fritzer-Szekeres, M; Handler, N; Horvath, Z; Jaeger, W; Murias, M; Saiko, P; Szekeres, T | 1 |
1 review(s) available for cytarabine and pyrogallol
| Article | Year |
|---|---|
[Progress in the drug therapy of cancer].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Cytarabine; Daunorubicin; Drug Synergism; Humans; Hydrazines; Hydroxyurea; Neoplasms; Nitroso Compounds; Picolinic Acids; Pyrogallol; Quinolines; Streptonigrin; Urea | 1968 |
2 other study(ies) available for cytarabine and pyrogallol
| Article | Year |
|---|---|
Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cytarabine; Deoxyribonucleotides; Drug Evaluation, Preclinical; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; NF-kappa B; Pyrogallol; Resveratrol; Ribonucleotide Reductases; Ribonucleotides; Stilbenes; Tumor Necrosis Factor-alpha; Wine | 2006 |
Antitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bisbenzimidazole; Cell Cycle; Cytarabine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Fluorescent Dyes; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Promyelocytic, Acute; Propidium; Pyrogallol; Stilbenes | 2006 |